Lepkifker E, Horesh N, Floru S
Department of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Acta Psychiatr Scand. 1988 Sep;78(3):391-5. doi: 10.1111/j.1600-0447.1988.tb06354.x.
The aim of this study was to assess life satisfaction and adjustment of lithium-treated affective patients in remission. Scores of life satisfaction and adjustment in four areas were obtained for two experimental groups of 50 unipolars and 50 bipolars and for two control groups of 50 healthy individuals and 50 patients with personality disorders. Subjects' self-assessments and psychiatrists' evaluation were rated using a modification of Cantril's ladder device. No significant differences were found between affective patients and healthy controls regarding life satisfaction and adjustment, whereas psychiatric controls scored significantly less on most indices. Moreover, the treating psychiatrists rated affective patients significantly higher than psychiatric controls and perceived them as actualizing their potential to a greater degree. Thus, it is concluded that neither the affective illness nor lithium as a prophylactic agent interfered with the patients' feelings of satisfaction or with manifest functioning while in remission.
本研究的目的是评估处于缓解期的接受锂盐治疗的情感障碍患者的生活满意度和适应情况。对两组各50名单相情感障碍患者和两组各50名双相情感障碍患者的生活满意度及四个领域的适应情况进行了评分,同时对两组各50名健康个体和50名人格障碍患者作为对照组进行了评分。采用对坎特里尔阶梯量表的修改版本对受试者的自我评估和精神科医生的评价进行评分。在生活满意度和适应方面,情感障碍患者与健康对照组之间未发现显著差异,而精神科对照组在大多数指标上得分显著较低。此外,治疗精神科医生对情感障碍患者的评分显著高于精神科对照组,并认为他们在更大程度上实现了自身潜力。因此,得出的结论是,无论是情感障碍疾病还是作为预防剂的锂盐,在缓解期均未干扰患者的满意度或明显功能。